Join to access to all OVN content. Join for Free
The art of leveraging your strengths to be a Kick Ass MSL
MSL career tips leadership insights becoming a top MSL performance evaluation for MSLs career advice for introverts

The art of leveraging your strengths to be a Kick Ass MSL


Share This Article


Summary

I’m joined by Cathy Andorfer, who leads a national team of MSLs and has agreed to give us a leader’s perspective on how to be great at your job.

In this episode:

  • How Cathy got to where she is now
  • What matters most to her as a director and other leaders in the company
  • What someone needs to do to be a top MSL
  • How do internal stakeholders evaluate the performance of their MSL teams? Of their individual MSLs?
  • How can MSLs separate themselves from their peers?
  • Can someone without any experience convince the manager to hire them
  • Advice for somebody who’s early in their career to make an impact with leadership to get noticed
  • Cathy from being an introvert to senior national director
  • Her advice for anyone out there early in their career, introvert or extrovert?
  • Cathy’s advice to be a kickass MSL

Click for Source
MSL career tips, leadership insights, becoming a top MSL, performance evaluation for MSLs, career advice for introverts

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Job Search Checklist for Aspiring Medical Science Liaisons
Partner Avatar Tom Caravela

Job Search Checklist for Aspiring Medical Science Liaisons

Podcast
New MSL: The 4 “Ts” to Prepare for and Overcome
Partner Avatar MSL Talk: Tom Caravela, Lauren Gardner

New MSL: The 4 “Ts” to Prepare for and Overcome

Podcast
"You Cannot Teach Someone How to be an MSL"
Partner Avatar MSL Talk: Tom Caravela, Kathleen Bailey

"You Cannot Teach Someone How to be an MSL"

Article
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
OVN Avatar Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis

Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis

Article
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
OVN Avatar Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Article
Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review
OVN Avatar Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy

Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review

Explore OVN